Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual fentanyl versus subcutaneous morphine for severe cancer pain
2013-003319-23Phase 4Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Oct 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cancer pain comparing Sublingual fentanyl with Subcutaneous morphine (2 arms). Primary endpoint: Primary analgesic effectiveness at 30 minutes. Started Oct 2013; status: completed.
02
Drugs
fentanylmorphine
03
Conditions
cancer pain
Beyond the preview
Go deeper on 2013-003319-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003319-23.